PLXNB1 and ovarian carcinoma: The Plexin-B1 levels in the supernatants of the myeloma cell lines (76 ± 140 ng/ml) were decreased compared to the respective levels of the ovarian cancer cell lines (963 ± 1440 ng/ml, p = 0.008, Fig. 1b).